Promotional Intelligence, by Compliance Forward
Our guests and topics range from Pharma/Biotech Regulatory Ad Promo insights, FDA Enforcement activities, Commercial Regulatory Strategy to pioneering approaches for compliance enablement with AI.
PI Episode 1 - SUCRAID Untitled Letter
In this episode, Jason and Virginia break down the recent enforcement letter regarding Sucraid, highlighting its misleading promotional materials. The FDA has flagged two emails targeting healthcare professionals for their claims about the product's indication and presentation of safety.
We dive into the details—what was wrong with the promotional emails? And what should be done differently to ensure compliance?
This conversation sheds light on the importance of accurate communication in healthcare. Let’s not forget: clarity in presenting risks is crucial for patient safety!
Compliance Forward Website
Connect with u...
